Advertisement

Topics

Latest "Amiee Lynn, Inc." News Stories

22:39 EDT 15th July 2018 | BioPortfolio

Here are the most relevant search results for "Amiee Lynn, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Amiee Lynn, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Amiee Lynn, Inc. for you to read. Along with our medical data and news we also list Amiee Lynn, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Amiee Lynn, Inc. Companies for you to search.

Showing "Amiee Lynn" News Articles 1–25 of 75

Tuesday 10th July 2018

HMP Announces Enhanced ISET Meeting; Independent CIO Meeting for 2019

Changes reflect need for highly specialized endovascular education and the growing demand for interventional oncology training MALVERN, Pa. (PRWEB) July 10, 2018 In a move designed to proactively address the growing need for highly specialized, interactive, and practical education for today's endovascular and vascular specialists, HMP, a leading healthcare event and education company, today a...


Friday 29th June 2018

Weatherbee Resources Announces Change of Ownership Effective July 1, 2018

Weatherbee Resources, Inc. transfers ownership to two executive employees HYANNIS, Mass. (PRWEB) June 29, 2018 Since 1997, Weatherbee Resources, Inc. has provided innovative products and consulting services to hospices across the country. To continue Weatherbee's mission to help hospices navigate increasing regulatory scrutiny and operational challenges, the founders and owners of Weatherbee,...

Wednesday 27th June 2018

Compassionate Release for Dying Prisoners Underused - Report

When Lynn Atkinson knew her cancer-ridden brother had six months to live, she asked the Connecticut prison where he was serving a sentence for robbery if he could come home early to die. Reuters Health Information


Tuesday 19th June 2018

IPS HEART, Resident of Johnson & Johnson Innovation, Uses Human Stem Cells for the First Time to Actually Reverse Heart Attack Damage

IPS HEART, resident of Johnson & Johnson Innovation, JLABS is pioneering the use of IPS cellular therapy for the replacement of heart tissue after heart attack, heart failure and duchenne cardiomyopathy. Recent results were presented at the 82nd Annual Scientific Meeting of the Japanese Circulation Society showing over 66% ejection fraction (EF) improv...

Monday 18th June 2018

2016 BioInfect Conference - Final Speakers Announced

Taking place on Thursday 3rd November, BioInfect 2016 will look at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance.Be the first to hear details of PwC's latest AMR thought leadership piece at BioInfect 2016. Prepared specifically for BioInfect the piece identifies the latest challenges, opportunities and thoughts of key opinion leaders f...

At CODAC Behavioral Healthcare, Sen. Sheldon Whitehouse Visits the Front Lines in the Fight Against the Opioid Epidemic

Sen. Sheldon Whitehouse recently visited a CODAC Behavioral Healthcare facility in Providence to see the current environment for addiction treatment. During the tour, CODAC staff discussed some of the challenges the recovery community continues to face. PROVIDENCE, R.I. (PRWEB) June 18, 2018 While Rhode Island has made significant headway in addressing the opioid crisis, health officials througho...

Herbal Essences Joins Forces With the Royal Botanic Gardens, Kew to Become First Global Hair Care Brand Endorsed by the World Leader in Plant Science

P&G-owned hair care brand Herbal Essences and the Royal Botanic Gardens, Kew – the world’s leader in plant science – are partnering together to bring cutting edge botanical science to our line-up of amazing shampoos and conditioners. This partnership is rooted in Kew’s expertise in plants. Herbal Essences is the first-ever global hair care brand to ha...

Thursday 14th June 2018

New Clinically Integrated Pediatrician Network From Children’s National to Provide Higher Quality Care for the Community’s Kids

A clinically integrated network (CIN) that serves children and the medical providers who care for them has been created for the Washington, D.C. region. More than a year of planning, development and market analysis by Children’s National Health System and community-based clinicians has resulted in the launch of the Pediatric Health Network. WASHINGTON (PRWEB) June 14, 2018 A clinically integrat...

Monday 11th June 2018

Cannabis Lifestyle Media and Brand Platform PRØHBTD Secures $12 Million Funding

Total financing includes a new USD $8 million Series A, led by Serruya Private Equity, The Delavaco Group and Cresco Capital with early participation by Donald Glover PRØHBTD, the leading cannabis lifestyle media and brand platform, has raised USD $12 million in funding, $8 million of which was recently secured from a Series A round of investment. In ...

Ensysce Biosciences to Participate in New Generation Analgesics Symposium at Annual Meeting of the College on Problems of Drug Dependence

Ensysce Biosciences, Inc., an integrated drug delivery company for both small and large molecules, today announced that D. Lynn Kirkpatrick, Ph.D., Chief Executive Officer, will be an invited speaker at the upcoming symposium titled New Generation Analgesics at the 80th Annual Meeting of the College on Problems of Drug Dependence (CPDD 2018). The meeting w...

Thursday 7th June 2018

Methadone and Buprenorphine—When to Use, What to Know

New Half-Day Workshop at the PAINWeek 2018 Pain Conference Will Explore Two Lesser-Known Analgesics MONTCLAIR, N.J. (PRWEB) June 07, 2018 At PAINWeek 2018, the program agenda will be augmented with 4 registration-only, limited attendance workshops designed to provide an in-depth examination of critical topics in pain management. The half- and full-day workshops will be led by senior PAINWeek facu...

AmpliPhi Biosciences Announces Presentation of AB-PA01 Bacteriophage Therapy Case Study at 41st European Cystic Fibrosis Conference

AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced a poster presentation of a successful case study of a patient with cystic fibrosis, suffering from recurrent multi-drug resistant (MDR) Pseudomonas aerug...

Wednesday 6th June 2018

Eisai/Biogen Remain In BACE Race As Alzheimer's Contenders Dwindle

Multiple competitors have ended development of BACE inhibitors for the treatment of Alzheimer's disease, but Eisai neurology executive Lynn Kramer...  

ECFC Submits Testimony to House Subcommittee on the Benefits of Consumer-Directed Health Plans

ECFC, the leading nonprofit organization promoting choice in benefit solutions, today submitted testimony to the House Ways and Means Subcommittee on Health. The hearing, “Lowering Costs and Expanding Access to Health Care through Consumer-Directed Health Plans” will examine trends in enrollment and demographics for health spending account holde...

Tuesday 5th June 2018

2019 Coding Updates Virtual Boot Camp: Preparing Coders for a Successful 2019

AudioEducator’s live boot camp will offer the latest coding updates, expert compliance strategies, and secrets to getting rightful reimbursement. DURHAM, N.C. (PRWEB) June 05, 2018 AudioEducator, a division of web-based training and corporate education leader ProEdTech, will host the 2019 CODING UPDATES VIRTUAL BOOT CAMP: Preparing Coders for a Successful 2019. The three-day boot camp will be h...

Caravan Health Announces Third Annual Accountable Care Symposium

Caravan Health today announced the call for speaker proposals for the 2018 Accountable Care Symposium, the cutting-edge learning and networking event for current and future participants in Accountable Care Organizations and other alternative payment models. The third annual event returns to Phoenix, Arizona on December 5 and 6 to discuss the biggest trends and innovations in population health. KAN...

Thursday 31st May 2018

Second Leading Cause of Dementia Commonly Misdiagnosed

Lewy Body Dementia (LBD) was publicized in 2014 when beloved actor/comedian Robin Williams was diagnosed with LBD following an autopsy. Before his death, Mr. Williams had been diagnosed and treated for Parkinson’s disease. BOCA RATON, Fla. (PRWEB) May 31, 2018 The Lewy Body Dementia Resource Center (LBDRC) announced today the expansion of its re

Tuesday 22nd May 2018

Evoqua Water Technologies Appoints Lynn Swann to Its Board of Directors

Evoqua Water Technologies Corp. (NYSE: AQUA) today announced Lynn Swann has joined its Board as an independent director, effective May 21, 2018. Swann’s addition brings the size of the Evoqua Board to nine members. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522005346/en/

Wednesday 16th May 2018

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

Multinational biotherapeutics company announces a new leadership team, expands its global footprint and advances an innovative portfolio of immune modulators for unmet medical needs HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-B-cell screening and analysis, today announced the completion of a $37.5 mill...

Tuesday 15th May 2018

Product Vision Takes Center Stage at the CPSI 2018 National Client Conference

CPSI (NASDAQ: CPSI), welcomes more than 1,300 client attendees, representing hospitals, skilled nursing facilities and clinics from across the U.S. at their annual client conference being held May 14 – 17 in New Orleans. Headlining the conference are CPSI’s vision and go-forward plan for product development and the Company’s focus on deliver...

Monday 14th May 2018

Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair

Study Evaluates Safety of First-of-Its-Kind Therapy Designed to Directly Target Systolic Heart Failure Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the expansion of the company’s U.S. feasibility study to evaluate the investigational AccuCinch® Ventricular Repair System designed for the treatment...

Wednesday 9th May 2018

NCPDP Annual Conference Recap: A Call for Collaboration to Develop Standards And Solutions That Improve the Patient Journey

NCPDP announced today highlights from its 2018 Annual Technology & Business Conference, Industry United to Improve the Patient Journey. (PRWEB) May 09, 2018 NCPDP announced today highlights from its 2018 Annual Technology & Business Conference, Industry United to Improve the Patient Journey. The Opening Keynote Panel provided a 360-degree view on “Data Challenges and Opportunities to Im...

Monday 30th April 2018

Study explores the down side of being dubbed 'class clown'

(University of Illinois at Urbana-Champaign) Being dubbed the class clown by teachers and peers has negative social repercussions for third-grade boys that may portend developmental and academic consequences for them, University of Illinois recreation, sport and tourism professor Lynn A. Barnett found in a new study.

Friday 27th April 2018

OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions

BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California. The findings further confirm that bilateral pulmonary embolism treated in as little as 2 hours with significantly less tissue plasminogen activator (tPA) than ...

Monday 23rd April 2018

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

First Gene Therapy Using AAV Approach Granted Regenerative Medicine Advanced Therapy Designation NEW YORK and CLEVELAND, April 23, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the US Food and Drug Admi...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks